| I N TR ODU C TI ON
Osteoarthritis (OA) is a multifactorial disease that affects the articular cartilage causing deterioration of the joint function. Cartilage injuries and trauma are difficult to repair even in young adults due to the poor regenerative potential of the cartilage tissue, and greatly accelerates OA development. 1 Current treatments of OA are mainly palliative and aim at pain and symptoms management rather than disease modification. 2 Lack of any disease modifying OA drugs (DMOADs) calls for new and effective therapies to repair and regenerate damaged articular cartilage, and to restore joint homeostasis to delay OA progression. anti-inflammatory factors that mitigate inflammation. 4 The role of inflammation in the development of OA is being increasingly recognized. 5 As such, the beneficial anti-inflammatory effects of MSC in prevention or delay of the onset of OA is of substantial interest. Currently, and pellets were maintained in culture for 21 days. 0.5 ml of freshly prepared complete chondrogenic medium was replaced every 2 days by complete aspiration of the medium carefully avoiding the pellet. 
| Collagen VI treatment and cell growth

| Gene expression analyses
For the monolayer cultures, total RNA was extracted using the RNeasy mini kit (Qiagen, Valencia, CA) and for pellet cultures, total RNA was 
| Statistical analyses
Data are reported as mean 6 standard deviation (SD). Statistical significance of data was determined by applying a two-tailed Student's t test and p values less than .05 are reported as significant.
| R E SU LTS
| Collagen VI (Col VI) treatment enhances hMSC proliferation
In the present study, we aimed to study the direct effect of soluble Col properties of chondrocytes leading to altered chondrocyte behavior and a spontaneous development of hip OA. 21 We therefore speculate that Col VI may modulate the cell stem proliferation through interacting with surface receptors that likely sense the biomechanical properties of the microenvironment. The identity of these receptors and the downstream signaling pathways will be further investigated in future studies.
In conclusion, in this study we have described a useful and effective method for MSC expansion utilizing a cartilage-specific factor, Col VI.
We envision that Col VI and similar biologics are promising candidates to enhance the effectiveness of MSC-based therapeutic approaches.
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